IRVINE, CA – joimax^®, the German-based market leader in technologies and training methods for full-endoscopic and minimally invasive spinal surgery, is excited to announce the global launch of its new generation tower, NAVENTO^® Navigation Endoscopic Tower. Optimized for endoscopic spine surgery with special settings for the safe treatment of sensitive structures, NAVENTO^® will be featured at the North American Spine Society (NASS) meeting in Boston later this month and at EUROSPINE in Vienna this October.

NAVENTO^®, the fully integrated fourth generation endo-tower, contains everything a surgeon needs to perform a successful procedure. The tower boasts updated design features for enhanced usability and is composed of six devices that work in unison to give the user the best possible surgical experience:

1. Vitegra^®, the brain of NAVENTO^®, offers complete documentation and data management.
2. Camsource^® LED provides optimal clarity up to 4K resolution.
3. Intracs^®, the newest device from joimax^®, delivers electromagnetic navigation at the instrument’s tip.
4. Shrill^®, the shaver drill system, with the newest generation recently launched, provides optimal RPMs and torque management.
5. Endovapor^® 2 poses electrosurgical offerings for monopolar and bipolar settings.
6. Versicon^®, delivers fluid and pressure regulation.

“joimax^® continues to lead the endoscopic spine market through innovations in technologies aimed to increase the user experience and provide spinal patients with an ultra-minimally invasive treatment option,” stated Christoph Hofstetter, M.D., Ph.D., associate professor in the Department of Neurological Surgery at the University of Washington.

Wolfgang Ries, CEO and founder of the joimax^® group, confirmed, “NAVENTO^® pulls together the latest technologies forming one complete, seamlessly integrated spinal endoscopic package.”

NAVENTO^®, along with the full suite of joimax^® endoscopic technologies will be showcased at NASS, booth #3512, and at EUROSPINE, booth #04.

Karlsruhe (GER) — German-based joimax^®, the market leader in technologies and training methods for full-endoscopic and minimally invasive spinal surgery, is excited to announce that it has received FDA clearance to market the EndoLIF^® Delta-Cage and EndoLIF^® DoubleWedge-Cage in the United States. Delta-Cages and DoubleWedge-Cages are intended for intervertebral body fusion procedures for various diseases of the lumbar spine, such as degenerative disc disease.

Now in its 20^th anniversary year, joimax^® sets another milestone by providing a family of 3D printed titanium cages. The complete EndoLIF^® product portfolio consists of the Delta-Cage, the DoubleWedge-Cage, and the O/On-Cage. All three models are designed with special features:

• 3D printed titanium for excellent bone ingrowth, fillable with bone or bone substitute material, pre- or post-insertion
• Anatomical shape and lordotic correction options for OLIF, TLIF, and PLIF procedures
• “Over-the-wire” implantation for optimal targeted positioning in the intervertebral disc space
• Endoscopic control of all surgical steps due to the EndoLIF^® platform technology

“It is impressive how well these cages ensure primary stability, especially the DoubleWedge-Cage,” says Dr. Ralf Wagner, head surgeon and founder of the Ligamenta Spine Centre in Frankfurt.

Many other experts including, Dr. Florian Zentz, head surgeon of the spine center in Tutzing (Munich), Dr. Ricardo Casal Grau, orthospine surgeon from Madrid, and Dr. J. N. Alastair Gibson, spinal surgeon from Edinburgh, supported the development of the joimax^® cages.

“With FDA clearance of two of our cages, our EndoLIF^® platform gets more complete; the next major step in endoscopic spinal surgery is endoscopically-assisted fusion,” says joimax^® Founder and CEO Wolfgang Ries. “More and more centers are proving the efficacy of these procedures in studies, demonstrating once again the major benefits of endoscopy in fusion. So far, our cages are well established in Europe and in selected centers in Asia, and now we are entering the USA, the biggest market for spinal fusion”.

Endoscopy in Pain Therapy

Focus on Facet Joint – Sacroiliac Joint – Peripheral nerves
New Endoscopic Approach

The aim of the Course of Endoscopy in Pain Therapy is to develop endoscopic techniques in the treatment of common diseases like Low Back Pain, Sacroileitis and Peripheral nerves pain. This course gives the participants an overview of endoscopic possibilities and new approaches in Pain Therapy.

The course is divided in two sessions, a frontal didactical part with an explanation of anatomy and physiopathology of facet joint pain, sacroliliac pain and peripheral nerves disturbs, and it is followed by a practice part with 2 / 3 surgical procedures performed by Dr. Meloncelli and his equipe with a direct explanation of surgical aspects.

At a glance:

One day meeting with live surgery
Rome, November 24, 2018, 9:30 – 17:00

Course director: Dr. Stefano Meloncelli
Secretary: Dr. Ignazio Urti
Faculty: Dr. Marco Divizia, Dr. Giorgio Germani

Location:
Casa di Cura „Valle Giulia“
Via Guiseppe de Notaris 2, Roma
www.clinicavallegiulia.it

Number of Participants: 10
Subscription: 600 Euro

Reservation and information:
Medical Training
phone number:+39 329 771 41 69
email: infomedicaltraining@gmail.com

sponsored by

Karlsruhe (GER) – joimax^® and Trang Thi are pleased to announce their partnership in bringing the joimax^® full-endoscopic and minimally invasive spinal surgery technology to the Southern Provinces of Vietnam including Da Nang market.  joimax^® a German-based company is a recognised market leader in these technologies and training methods with a history of innovation in endoscopic spine surgery since 2001.

Endoscopic Spine Surgery has been growing steadily in popularity since the late 1990’s and there has been exponential growth in the technique in the past 10 years. The distributor Trang Thi and joimax^® are pursuing a long term corporation to provide a broader surgical choice for patients considering spinal surgery. “joimax^® is looking forward to working with a partner as strong as Trang Thi, says joimax^® Founder and CEO Wolfgang Ries and adds, “a company that has the necessary personnel, expertise, as well as the corresponding specialization and penetration of the market”.

“We’re very pleased to collaborate with joimax^®,” comments Trang Thi Medical Co., Ltd Director Dieu Linh Nguyen. “Endoscopic spine surgery is a technique that enables patients to have access to truly minimally invasive surgical procedures of the spine.” Thus, joimax^® strengthens its sales activities in Southern Provinces of Vietnam including Da Nang and enters into another important partnership across APAC.

About Trang Thi Medical Co. Ltd
Trang Thi Medical Co., Ltd (TRANG THI) is one among key players in Vietnam market, providing complete solutions for neuro and spine surgery. During the nine years of operation, TRANG THI has cooperated with many well-known manufacturers, transfering advanced and innovative technology to hospitals and healthcare centers. With the mission of community health, Trang Thi always strive to make a real difference to people’s lives.

Karlsruhe (GER) – joimax^®, the German-based market leader in technologies and training methods for full-endoscopic and minimally invasive spinal surgery, is pleased to announce a new partnership with Transmedic Group, a top medical device distributor headquartered in Singapore. In this exclusive deal, Transmedic will represent joimax^® in Singapore, Hong Kong, Philippines and Indonesia.

The long-term partnership will provide a broader surgical choice for patients considering endoscopic minimally invasive spinal surgery in these markets. With recent advances in the field of endoscopic discectomy (ED), the procedure has potential to supersedemicrodiscectomy (MD) as the gold standard of care in management of lumbar disc disease, as the latest literature suggests.

“joimax^® is very much looking forward to working with Transmedic Group,” says joimax^® Founder and CEO Wolfgang Ries. “With the rising popularity of endoscopic approaches in the management of spinal diseases, we’re able to deliver the highest standard of patient care, strengthen our sales activities, and enter into another important partnership across APAC.” 

Teo Kee Meng, managing director of Transmedic Group commented, “We’re very pleased to partner with joimax^®. With their technological advancements and use of new spinal access corridors, a major prevention of spinal structure collateral damage is assured, allowing for significantly reduced complications and improved postoperative recovery times.”

About Transmedic Group
Transmedic Group was founded in 1980 with the aim of becoming the top specialist in the advanced medical technology area in Southeast Asia. Headquartered in Singapore, the privately held company has since grown its presence in seven countries with more than 500 employees, and is well-renowned as the leading provider of latest technologies in healthcare.

Karlsruhe (GER) – joimax^®, the German-based market leader in technologies and training methods for full-endoscopic and minimally invasive spinal surgery, is pleased to announce a new partnership with Australian medical device distributor, LifeHealthcare. The two companies have entered into a long-term relationship to provide a broader surgical choice for patients considering spinal surgery.

“We’re looking forward to working with a partner as strong as LifeHealthcare,” says joimax^® Founder and CEO Wolfgang Ries. “LifeHealthcare shares our goals and vision, ensuring that we are able to deliver the highest standards of patient care.”

Endoscopic spine surgery has been steadily growing in popularity since the late 1990’s with exponential growth in the technique for the past ten years. Surgeons throughout the world have reported that this type of surgery can assist patients in faster recovery, enabling them to reduce their post-operative stay.

“We’re very pleased to collaborate with joimax^®,” comments LifeHealthcare Chief Executive Officer Matt Muscio. “Endoscopic spine surgery is a technique that enables patients to have access to truly minimally invasive surgical procedures of the spine.”

Thus, joimax^® strengthens its sales activities in Australia and enters into another important partnership across APAC.

About LifeHealthcare

LifeHealthcare is a leading independent provider of healthcare solutions in Australia and New Zealand bringing healthcare professionals innovative medical devices by partnering with world class companies who share the vision of innovation and making a real difference to people’s lives. LifeHealthcare has been recognised as one of the Financial Times 1,000 High Growth Companies in Asia-Pacific. In May 2018, LifeHealthcare was acquired by Australia’s largest private equity fund, Pacific Equity Partners, a market leader that has been recognised as a Top 20 Consistent Performer Globally by Prequin. For further information, please visit www.lifehealthcare.com.au.

KARLSRUHE, Germany–(BUSINESS WIRE)–joimax^®, the German-based market leader in technologies and training methods for full-endoscopic and minimally invasive spinal surgery, launched its new iLESSYS^® Biportal Interlaminar Endoscopic Surgical System for the treatment of spinal disorders at the EUROSPINE 2023 Annual Meeting in Frankfurt and at the SMISS Annual Forum (Society for Minimally Invasive Spine Surgery) in Las Vegas, marking its global debut. This week, it will be presented at the NASS meeting (North American Spine Society) in Los Angeles.

 

The new instrument set, iLESSYS® Biportal for unilateral biportal endoscopy (UBE), expands the wide range of joimax^® endoscopic offerings by separating the instrument working port from the endoscope, allowing for free relative movement between the two. The iLESSYS^® Biportal offers all instruments tailor-made for biportal spinal endoscopy, with:

• A special Triangulation Tool to simplify the access triangulation of two ports
• Biportal specific working tubes with inbuilt irrigation outflow control for precise water management
• Larger, more powerful tools for effective tissue ablation and resection

“This system is excellent and will allow me to perform the surgeries not only biportally but also bimanually,” stated Javier Quillo-Olvera, M.D., spinal neurosurgeon and an expert in biportal surgery at the Brain and Spine Care Group, Querétaro, Mexico. “It allows me to use the iLESSYS® Pro working channel endoscope. I’m excited to use it with my patients.”

EUROSPINE attendees were impressed that this comprehensive system could be used as a biportal system and available for bimanual surgical procedures. Moreover, the iLESSYS^® played a key role during the expert talks, spurring debate about when to use the transforaminal (TESSYS®) and when to use the interlaminar (iLESSYS®) approach for a given spinal disease.

“The system will be part of the ESPINEA^® training and education program and will be fully implemented in the workshop courses by the end of the year,” commented Wolfgang Ries, CEO and founder of the joimax^® group. “We´ve already lined up a range of surgical faculty in Europe (Dr. Ralf Wagner, Dr. Maxime Challali, Dr. Raed Abohussein, Dr. Miguel Loureiro), in the Americas (Dr. Peter Derman, Dr. Meng Huang, Dr. Javier Quillo-Olvera) and in Asia (Prof. Si-Young Park, Dr. Junseok Bae) among others in each of these regions, with many more to follow.”

 

 

(Karlsruhe-GER, 26 June 2020)
Karlsruhe (GER) – joimax^®, the German-based market leader in technologies and training methods for full-endoscopic and minimally invasive spinal surgery, is pleased to announce a new countrywide distributor in Taiwan, Hi-Clearance Inc. With the aim of building an effective, long-term relationship, the strategic supplier partnership is a further milestone in the international growth of joimax^® .

“Hi-Clearance is our ideal sales and service partner,” says joimax^® CEO and Founder Mr. Wolfgang Ries. With their streamlined structure and process in place, we are confident joimax^® will penetrate this new market very successfully”.

Hi-Clearance Inc. has over 239 employees, and is a well-known supplier of medical materials and equipment in Taiwan. “We are very pleased about the new strategic partnership and are excited to continue the strong growth of both companies,” states Hi-Clearance Chairman Mr. John Lee and President Mr. Ernie Chen. “We are dedicated to establishing joimax^® as the leading brand of endoscopic spine surgery in Taiwan.”

Hi-Clearance Inc. is headquartered in Taipei with four other branches spread across the country. The main business includes products for Hemodialysis, Critical Care, Dental, Cardiology, Homecare Devices, Nutrition and a major Spine Surgery Division. In 2019, sales were USD 107 million.

KARLSRUHE, Germany–(BUSINESS WIRE)–joimax®, the German-based market leader in technologies and training methods for full-endoscopic and minimally invasive spinal surgery, presented at the ESPINEA® World Summit at the prestigious Royal College of Surgeons of Edinburgh, PASMISS in Taiwan, NASSi in Bangkok, the ASEAN MISST in Jakarta, and at the first Annual Endoscopic Spine Surgery Symposium at the Seattle Science Foundation.

 

 

From July 13 to 15 more than 80 attendees from 22 countries connected at the ESPINEA® World Summit. “This historic event was a major milestone in the educational training activity of ESPINEA^®, where we are proud to guide highly active surgeons from around the world within this encouraging field of endoscopic spinal therapy,” concluded ESPINEA^® board members Dr. Alastair Gibson and Dr. Menno Iprenburg.

The July events provided joimax^® the ideal opportunity to launch the highly anticipated surgical access systems, iLESSYS^® Biportal and TESSYS^® Trans SAP, along with the new electrosurgical probe, Vaporace^® Bipo, which are key to the soon-to-be announced endoscopic expandable fusion platform.

joimax^® will also share its latest developments at EUROSPINE in Frankfurt, affording participants an opportunity to attend an open house at their global headquarters in Karlsruhe, where they will further learn about joimax^®’s research and manufacturing capabilities. Moreover, the joimax^® US team will welcome NASS attendees in its hometown of Los Angeles.

“We are excited to see the widespread acceptance of endoscopic spine surgery around the globe,” said joimax^® Founder and CEO Wolfgang Ries. “Having reached a tipping point, the NASS endoscopic “Surgical Stadium” event, will be another highlight the spine community can look forward to”. For further information and event registration, contact joimax^®.